Dan Brounstein, Senior Vice President & President of North America at Saluda Medical, has over 20 years of experience in the medical device field holding senior roles in marketing, sales and engineering. He has spent the last 4 years leading the US strategy to enter the $2B spinal cord stimulation market, which includes building out the commercial organization and execution of the Evoke Study, the first double-blinded approval study in the space. Prior to joining Saluda, Dan held the position of Vice-President Marketing and Clinical Operations at Spinal Modulation, where he led US operations for their IDE pivotal study and directed the marketing and business strategy. He has a B.S. in Biomedical Engineering from UC San Diego and an M.B.A from the Haas School of Business, UC Berkeley.
Closing Keynote — Cutting-edge Neuromodulation Tackles Disease on All Fronts